High frequencies of CD171-positivity were also detected in ovary serous carcinoma (87%, median value of positive cells 60%, Figure 3A), malignant mesothelioma (70%, Figure 3B), and testicular embryonal carcinoma (60%). This evidence concerns the gene L1CAM and ovarian serous adenocarcinoma.